MULT1-Encoding DNA Alleviates Schistosomiasis-Associated Hepatic Fibrosis via Modulating Cellular Immune Response

References

• Mondiale de laSanté O; World Health Organization. Schistosomiasis: number of people treated worldwide in 2014. Wkly Epidemiol Rec. 2016;91(5):53–60.
   PubMedGoogle Scholar
• Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383(9936):2253–2264.
   PubMed Web of Science ®Google Scholar
• Colley DG, Secor WE. Immunology of human schistosomiasis. Parasite Immunol. 2014;36(8):347–357.
   PubMed Web of Science ®Google Scholar
• Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, McManus DP. Immunopathogenesis of human schistosomiasis. Parasite Immunol. 2009;31(4):163–176.
   PubMed Web of Science ®Google Scholar
• Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev. 2004;201:156–167.
   PubMed Web of Science ®Google Scholar
• Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2(7):499–511.
   PubMed Web of Science ®Google Scholar
• Fairfax K, Nascimento M, Huang SCC, Everts B, Pearce EJ. Th2 responses in schistosomiasis. Semin Immunopathol. 2012;34(6):863–871.
   PubMed Web of Science ®Google Scholar
• Cheever AW, Finkelman FD, Cox TM. Anti-interleukin-4 treatment diminishes secretion of Th2 cytokines and inhibits hepatic fibrosis in murine schistosomiasis japonica. Parasite Immunol. 1995;17(2):103–109.
   PubMed Web of Science ®Google Scholar
• Brunet LR, Finkelman FD, Cheever AW, Kopf MA, Pearce EJ. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J Immunol. 1997;159(2):777–785.
   PubMed Web of Science ®Google Scholar
• Fallon PG, Richardson EJ, McKenzie GJ, McKenzie ANJ. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: is a profibrotic agent. J Immunol. 2000;164(5):2585–2591.
   PubMed Web of Science ®Google Scholar
• Sugimoto R, Enjoji M, Nakamuta M, et al. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int. 2005;25(2):420–428.
   PubMed Web of Science ®Google Scholar
• Liu Y, Meyer C, Muller A, et al. IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF-beta-Independent Smad Signaling. J Immunol. 2011;187(5):2814–2823.
   PubMed Web of Science ®Google Scholar
• Figueiredo AL, Domingues AL, Melo WG, et al. Receptor antagonist of IL-13 exerts a potential negative regulation during early infection of human schistosomiasis. Scand J Immunol. 2016;84(5):284–290.
   PubMed Web of Science ®Google Scholar
• Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest. 1999;104(6):777–785.
   PubMed Web of Science ®Google Scholar
• Liu TJ, Dhanasekaran SM, Jin H, et al. FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol. 2004;164(4):1315–1326.
   PubMed Web of Science ®Google Scholar
• Zheng B, Zhang J, Chen H, et al. T lymphocyte-mediated Liver immunopathology of schistosomiasis. Front Immunol. 2020;11:61.
   PubMed Web of Science ®Google Scholar
• Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Mediators Inflamm. 2001;10(2):51–59.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan S, Wiehagen KR, Pulko V, et al. Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR: peptide-MHC interaction, ICAM-1, IL-12, and IFN-gamma (Retracted article. See vol. 184, pg. 6555, 2010). J Immunol. 2007;178(6):3583–3592.
   PubMed Web of Science ®Google Scholar
• Baroni GS, D’Ambrosio L, Curto P, et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology. 1996;23(5):1189–1199.
   PubMed Web of Science ®Google Scholar
• Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 1999;397(6721):710–713.
   PubMed Web of Science ®Google Scholar
• Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity. 2002;17(1):19–29.
   PubMed Web of Science ®Google Scholar
• Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2003;100(16):9452–9457.
   PubMed Web of Science ®Google Scholar
• Zafirova B, Wensveen FM, Gulin M, Polic B. Regulation of immune cell function and differentiation by the NKG2D receptor. Cell Mol Life Sci. 2011;68(21):3519–3529.
   PubMed Web of Science ®Google Scholar
• Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285(5428):727–729.
   PubMed Web of Science ®Google Scholar
• Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol. 2005;175(4):2144–2151.
   PubMed Web of Science ®Google Scholar
• Nielsen MM, Dyring-Andersen B, Schmidt JD, et al. NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity. J Invest Dermatol. 2015;135(5):1311–1319.
   PubMed Web of Science ®Google Scholar
• Lu S, Zhang J, Liu D, et al. Nonblocking monoclonal antibody targeting soluble MIC revamps endogenous innate and adaptive antitumor responses and eliminates primary and metastatic tumors. Clin Cancer Res. 2015;21(21):4819–4830.
   PubMed Web of Science ®Google Scholar
• Hou X, Yu F, Man S, et al. Negative regulation of Schistosoma japonicum egg-induced liver fibrosis by natural killer cells. PLoS Negl Trop Dis. 2012;6(1):e1456.
   PubMed Web of Science ®Google Scholar
• Gong Z, Luo QZ, Lin L, et al. Association of MICA gene polymorphisms with liver fibrosis in schistosomiasis patients in the Dongting Lake region. Braz J Med Biol Res. 2012;45(3):222–229.
   PubMed Web of Science ®Google Scholar
• Basher F, Dhar P, Wang X, et al. Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy. J Hematol Oncol. 2020;13(1):74.
   PubMed Web of Science ®Google Scholar
• Ferrari de Andrade L, Kumar S, Luoma AM, et al. Inhibition of MICA and MICB shedding elicits NK-cell-mediated immunity against tumors resistant to cytotoxic T cells. Cancer Immunol Res. 2020;8(6):769–780.
   PubMed Web of Science ®Google Scholar
• Carayannopoulos LN, Naidenko OV, Fremont DH, Yokoyama WM. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol. 2002;169(8):4079–4083.
   PubMed Web of Science ®Google Scholar
• Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6(7):1258–1266.
   PubMed Web of Science ®Google Scholar
• Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther. 1999;10(10):1735–1737.
   PubMed Web of Science ®Google Scholar
• Lisi PJ, Huang CW, Hoffman RA, Teipel JW. A fluorescence immunoassay for soluble antigens employing flow cytometric detection. Clin Chim Acta. 1982;120(2):171–179.
   PubMed Web of Science ®Google Scholar
• Chuah C, Jones MK, Burke ML, McManus DP, Gobert GN. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 2014;30(3):141–150.
   PubMed Web of Science ®Google Scholar
• Bai Y, Guan F, Zhu F, et al. IL-33/ST2 axis deficiency exacerbates hepatic pathology by regulating Treg and Th17 cells in murine schistosomiasis japonica. J Inflamm Res. 2021;14:5981–5998.
   PubMed Web of Science ®Google Scholar
• Long EO. Versatile signaling through NKG2D. Nat Immunol. 2002;3(12):1119–1120.
   PubMed Web of Science ®Google Scholar
• Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3(10):781–790.
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang X, Wei Y, et al. Functional inhibition of natural killer cells in a BALB/c mouse model of liver fibrosis induced by Schistosoma japonicum infection. Front Cell Infect Microbiol. 2020;10:598987.
   PubMed Web of Science ®Google Scholar
• Xiao J, Guan F, Sun L, et al. B cells induced by Schistosoma japonicum infection display diverse regulatory phenotypes and modulate CD4(+) T cell response. Parasit Vectors. 2020;13(1):147.
   PubMed Web of Science ®Google Scholar
• Chen D, Xie H, Cha H, et al. Characteristics of Schistosoma japonicum infection induced IFN-gamma and IL-4 co-expressing plasticity Th cells. Immunology. 2016;149(1):25–34.
   PubMed Web of Science ®Google Scholar
• Stojanovic A, Correia MP, Cerwenka A. The NKG2D/NKG2DL axis in the crosstalk between lymphoid and myeloid cells in health and disease. Front Immunol. 2018;9:827.
   PubMed Web of Science ®Google Scholar
• Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol. 2007;85(2):148–154.
   PubMed Web of Science ®Google Scholar
• Xu F, Cheng R, Miao S, et al. Prior Toxoplasma gondii infection ameliorates liver fibrosis induced by Schistosoma japonicum through inhibiting Th2 response and improving balance of intestinal flora in mice. Int J Mol Sci. 2020;21:8.
   Web of Science ®Google Scholar
• Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian ZG, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology. 2006;130(2):435–452.
   PubMed Web of Science ®Google Scholar
• Mitra A, Satelli A, Yan J, et al. IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-Rae1 interaction between NKT and activated hepatic stellate cells in mice. Hepatology. 2014;60(6):2027–2039.
   PubMed Web of Science ®Google Scholar
• Strid J, Sobolev O, Zafirova B, Polic B, Hayday A. The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy. Science. 2011;334(6060):1293–1297.
   PubMed Web of Science ®Google Scholar
• Asseman C, Pancre V, Quatennens B, Auriault C. Schistosoma mansoni-infected mice show augmented hepatic fibrosis and selective inhibition of liver cytokine production after treatment with anti-NK1.1 antibodies. Immunol Lett. 1996;54(1):11–20.
   PubMed Web of Science ®Google Scholar
• Kumar S. Natural killer cell cytotoxicity and its regulation by inhibitory receptors. Immunology. 2018;154(3):383–393.
   PubMed Web of Science ®Google Scholar
• Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 2008;9(5):495–502.
   PubMed Web of Science ®Google Scholar
• Watzl C. The NKG2D receptor and its ligands-recognition beyond the “missing self”? Microbes Infect. 2003;5(1):31–37.
   PubMed Web of Science ®Google Scholar
• Stokic-Trtica V, Diefenbach A, Klose CSN. NK cell development in times of innate lymphoid cell diversity. Front Immunol. 2020;11:813.
   PubMed Web of Science ®Google Scholar
• Vosshenrich CA, Di Santo JP. Developmental programming of natural killer and innate lymphoid cells. Curr Opin Immunol. 2013;25(2):130–138.
   PubMed Web of Science ®Google Scholar
• Huntington ND, Tabarias H, Fairfax K, et al. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol. 2007;178(8):4764–4770.
   PubMed Web of Science ®Google Scholar
• Cheng YL, Song WJ, Liu WQ, Lei JH, Kong Z, Li YL. The effects of interleukin (IL)-12 and IL-4 deficiency on worm development and granuloma formation in Schistosoma japonicum-infected mice. Parasitol Res. 2012;110(1):287–293.
   PubMed Web of Science ®Google Scholar
• Schwartz C, Oeser K, Prazeres da Costa C, Layland LE, Voehringer D. T cell-derived IL-4/IL-13 protects mice against fatal Schistosoma mansoni infection independently of basophils. J Immunol. 2014;193(7):3590–3599.
   PubMed Web of Science ®Google Scholar
• van Lier RA, Borst J, Vroom TM, et al. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol. 1987;139(5):1589–1596.
   PubMed Web of Science ®Google Scholar
• Gravestein LA, Nieland JD, Kruisbeek AM, Borst J. Novel mAbs reveal potent co-stimulatory activity of murine CD27. Int Immunol. 1995;7(4):551–557.
   PubMed Web of Science ®Google Scholar
• Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C. CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci U S A. 1995;92(24):11249–11253.
   PubMed Web of Science ®Google Scholar
• Grant EJ, Nussing S, Sant S, Clemens EB, Kedzierska K. The role of CD27 in anti-viral T-cell immunity. Curr Opin Virol. 2017;22:77–88.
   PubMed Web of Science ®Google Scholar
• Robbins SH, Nguyen KB, Takahashi N, Mikayama T, Biron CA, Brossay L. Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J Immunol. 2002;168(6):2585–2589.
   PubMed Web of Science ®Google Scholar
• Greenberg SA, Kong SW, Thompson E, Gulla SV. Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models. Oncotarget. 2019;10(14):1399–1406.
   PubMedGoogle Scholar
• Tonby K, Mortensen R, Ruhwald M, Dyrhol-Riise AM, Jenum S. KLRG1-expressing CD4 T cells are reduced in tuberculosis patients compared to healthy Mycobacterium tuberculosis-infected subjects, but increase with treatment. J Infect Dis. 2019;220(1):174–176.
   PubMed Web of Science ®Google Scholar
• Herndler-Brandstetter D, Ishigame H, Shinnakasu R, et al. KLRG1(+) effector CD8(+) T cells lose KLRG1, differentiate into all memory T cell lineages, and convey enhanced protective immunity. Immunity. 2018;48(4):716–729 e718.
   PubMed Web of Science ®Google Scholar